A practical approach may be used to offer mind-body regulation training to medical students, according to research published in the Fall issue of the Annals of Behavioral Science and Medical Education.
Xiaflex (collagenase clostridium histolyticum) has been approved by the U.S. Food and Drug Administration to treat Peyronie's disease. The drug -- first sanctioned three years ago to treat Dupuytren's contracture -- is the first medication to be approved by the agency to treat Peyronie's.
The final hospital outpatient and ambulatory surgical center (ASC) payment rule will give hospitals and ASCs the ability to lower costs, according to a report from the Centers for Medicare & Medicaid Services (CMS).
Concerns surround implementation of the Medicare Hospital Readmissions Reduction Program, according to a policy brief published online Nov. 12 in Health Affairs.
The US Food and Drug Administration (FDA) has approved Xiaflex (collagenase clostridium histolyticum) as the first non-surgical treatment for Peyronie’s disease.
Initiation of health care reform in Massachusetts correlated with a reduction in intensive care unit (ICU) patients without insurance but did not significantly change ICU use or mortality among ICU patients.
Global health disparities could be reduced considerably by 2035 using an investment framework, according to a report published Dec. 3 in The Lancet.
The US Food and Drug Administration on Monday began the process of regulating compounding pharmacies. Under the Drug Quality and Security Act, signed into law Nov. 27 by President Barack Obama, these pharmacies are being encouraged to register with the FDA. The agency will then classify them as outsourcing pharmacies, enabling them to sell bulk drugs to hospitals and other health care facilities.
Various nonantibiotic prophylaxis options are available, some of which may be beneficial for adults with recurrent urinary tract infections, according to a review and meta-analysis published in the December issue of The Journal of Urology.
Physician volunteer programs can revive doctors' passion for medicine, according to an article published Nov. 11 in Medical Economics.